This inventor holds 1 USPTO granted patent. Top assignee: University of Michigan. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Luke Bugada in Nano-Satellite Complexes
Introduction
Luke Bugada is an innovative inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of nano-satellite technology, particularly in the development of complexes that have potential applications in cancer treatment. His work is characterized by a focus on biocompatible materials and advanced nanoparticle systems.
Latest Patents
Luke Bugada holds a patent for his invention titled "Nano-satellite complexes." This invention provides methods, compositions, systems, and kits that include nano-satellite complexes. These complexes consist of a core nanoparticle complex with a biocompatible coating surrounding a nanoparticle core. The invention also features 3-25 satellite particles that are attached to or absorbed by the biocompatible coating. Additionally, a plurality of antigenic peptides is conjugated to or absorbed by the satellite particles. In some embodiments, the administration of these nano-satellite complexes to subjects with cancer can achieve long-term cancer remission, especially when combined with immune checkpoint inhibitors like αPD1. Luke Bugada has 1 patent to his name.
Career Highlights
Luke Bugada is affiliated with the University of Michigan, where he conducts his research and development work. His innovative approach to nano-satellite technology has positioned him as a notable figure in the field. His research aims to bridge the gap between nanotechnology and medical applications, particularly in oncology.
Collaborations
Luke collaborates with talented individuals such as Duxin Sun and Ryan Clauson. Their combined expertise enhances the research and development efforts at the University of Michigan, fostering an environment of innovation and discovery.
Conclusion
Luke Bugada's work in nano-satellite complexes represents a significant advancement in the intersection of nanotechnology and cancer treatment. His contributions are paving the way for new therapeutic strategies that could improve patient outcomes.